Public Policy

The Analytic for Hemodynamic Instability tool can identify hemodynamic instability with 96% sensitivity and detects stable patients with 85% specificity.
FDA grants De Novo classification to Fifth Eye's continuous hemodynamic status monitoring tool
By Mallory Hackett | 01:26 pm | March 02, 2021
The Analytic for Hemodynamic Instability tool can identify hemodynamic instability with 96% sensitivity and detects stable patients with 85% specificity.   
FDA's enforcement discretion for digital health is more ambiguous than ever in 2021
By Dave Muoio | 03:06 pm | February 25, 2021
Industry regulatory leaders outline the best approaches for digital health companies looking to make sense of FDA's long-in-the-tooth enforcement discretion guidelines.
HIMSSCast: Is the FDA taking digital health regulation in the right direction?
By MobiHealthNews | 12:42 pm | October 09, 2020
Bradley Merrill Thompson, an FDA-watcher, lawyer and occasional MobiHealthNews guest contributor, joins the MobiHealthNews team for a closer look at what the FDA has been up to around digital health and AI.
HIMSSCast: FDA grapples with home COVID-19 testing, moves forward with Pre-Cert Program
By HIMSS Media | 05:31 pm | March 30, 2020
The HIMSS Media team gives a recap of recent headlines surrounding the FDA, COVID-19 and new digital health software products.